⌘K
Loading ticker…
As of 2026-08-24, Aclarion, Inc. Common Stock (ACON) has a 3-month relative strength percentile of 22 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 39. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 7.9%, relative volume 0.74×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
ACON appears in 1 ETF as of Mar 2026: VXF at 0.00% weight, $22K notional.
Held by 1 ETFs · $22K across latest filings · largest weight 0.00% (VXF).
Top 1 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VXFVanguard Extended Market ETF | 0.00% | $22K | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Attention is elevated versus its own recent norm without the relative strength to match — the loud-but-lagging pattern. Worth a skeptical eye; not a short signal.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ACON Jan avg: -31.61% median: -26.52% win: 25% σ: 40.12% n: 4 2022-04-25 → 2026-07-31 | ACON Feb avg: -35.27% median: -35.02% win: 25% σ: 41.71% n: 4 2022-04-25 → 2026-07-31 | ACON Mar avg: -24.21% median: -14.06% win: 25% σ: 45.46% n: 4 2022-04-25 → 2026-07-31 | ACON Apr avg: -14.94% median: -8.92% win: 20% σ: 17.40% n: 5 2022-04-25 → 2026-07-31 | ACON May avg: 3.35% median: -0.03% win: 40% σ: 33.84% n: 5 2022-04-25 → 2026-07-31 | ACON Jun avg: -11.65% median: -12.20% win: 20% σ: 18.76% n: 5 2022-04-25 → 2026-07-31 | ACON Jul avg: -6.10% median: -7.64% win: 40% σ: 14.11% n: 5 2022-04-25 → 2026-07-31 | ACON Aug avg: -6.63% median: -3.70% win: 50% σ: 20.64% n: 4 2022-04-25 → 2026-07-31 (current) | ACON Sep avg: -18.47% median: -21.16% win: 25% σ: 18.39% n: 4 2022-04-25 → 2026-07-31 | ACON Oct avg: 11.07% median: 3.19% win: 100% σ: 17.69% n: 4 2022-04-25 → 2026-07-31 | ACON Nov avg: -17.24% median: -19.37% win: 0% σ: 10.80% n: 4 2022-04-25 → 2026-07-31 | ACON Dec avg: -24.29% median: -25.32% win: 0% σ: 2.96% n: 4 2022-04-25 → 2026-07-31 |